An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)
Joined January 2009
- Tweets 12,407
- Following 4,431
- Followers 31,352
- Likes 5,208
7,441 Photos and videos
Pinned Tweet
Now streaming on CancerSpeak! 🎙️ Antibody–Drug Conjugates: Clinical Perspectives from Europe.
Accompanying the new ADC supplement in Cancer, this episode explores toxicities, resistance mechanisms, and next-generation ADC strategies.
cancerspeak.podbean.com/e/an…
#ASCO26 @OncoAlert
2
9
6
711
đź“Ł ICYMI: We've launched Direct to CANCER, an expedited review process for potentially practice-changing manuscripts that were rejected after peer review by high-impact journals for reasons of scope or priority.
Learn more: acsjournals.onlinelibrary.wi…
@OncoAlert
4
4
424
New editorial by Drs. Gleneara E. Bates-Pappas Jamie S. Ostroff of @MSKCancerCenter | Breaking barriers: Opt-out tobacco dependence treatment in oncology care
acsjournals.onlinelibrary.wi…
@OncoAlert
4
6
868
Don't forget: The @AmericanCancer Society Journals are now on YouTube! đź“ş
Watch author summaries, CancerSpeak podcast episodes, Editor Spotlights, and more. New videos added regularly.
Subscribe: youtube.com/@AmericanCancerS…
@OncoAlert @RamalingamMD
1
120
Working in #pedonc, #ayacsm, or a related field? Follow @PedAYAJournal for updates on our new #OpenAccess journal.
Hear from @billdahutmd on how the journal aims to support research momentum across pediatric & AYA oncology.
See more: acsjournals.onlinelibrary.wi…
@OncoAlert
7
9
878
Higher daily steps predicted better subsequent physical function, especially in survivors. These results highlight the importance of promoting physical activity during cancer survivorship care.
#OpenAccess 🔗: acsjournals.onlinelibrary.wi…
@OncoAlert #ExerciseOncology
5
5
293
⚖️ A new editorial responds to a recent @AmericanCancer study on racial and rural disparities in cancer survival, and warns that proposed cuts to health care spending could widen these gaps.
Editorial: acsjournals.onlinelibrary.wi…
Related study: acsjournals.onlinelibrary.wi…
@OncoAlert
5
6
675
New review đź“— The evolving landscape and clinical utility of circulating tumor DNA across the spectrum of urothelial carcinoma: A systematic review and framework for clinical integration
acsjournals.onlinelibrary.wi…
@OncoAlert
4
3
631
CAR-T cell therapy remains a promising frontier in neuro-oncology. đź§
Revisit this Top Advances overview from @Ravi_Medikonda1 & @MichaelLimMD on key developments in CAR-T therapy for brain tumors.
acsjournals.onlinelibrary.wi…
@OncoAlert @StanfordNsurg @Ethan_Schonfeld @Matthewabii
9
9
1,425
ACS Journal Cancer retweeted
Today! đź“Ł Our Associate Editor @JGladeBender, a leader in AYA oncology, joins a @CancerCare workshop to discuss issues affecting young adults with cancer, including treatment, survivorship, and navigating care.
Learn more about @PedAYAJournal: acsjournals.onlinelibrary.wi…
@OncoAlert
3
5
538
ACS Journal Cancer retweeted
A 2025 @AmericanCancer report on cancer treatment and survivorship statistics estimates that 18.6 million people in the US are living with a history of cancer.
This number is projected to rise to more than 22 million by 2035: acsjournals.onlinelibrary.wi…
@OncoAlert
4
3
673
Oncology clinical trials have long relied on RECIST criteria to define progression. In a recent commentary, @MSKCancerCenter researchers propose further study and reporting of how treatment failure is characterized.
acsjournals.onlinelibrary.wi…
@EChrisDee @PatelOncology @OncoAlert
8
13
880
Antibody–drug conjugates are evolving rapidly, and so are the questions surrounding their use.
In this CancerSpeak episode, Drs. @EmilianoCalvo_ and André Mansinho discuss ADC toxicities, resistance mechanisms, and the next wave of innovation: cancerspeak.podbean.com/e/an…
@OncoAlert
8
11
813
New findings support an association between presence of Fusobacterium nucleatum in colorectal cancer (CRC) tumor tissue and CRC-specific mortality, particularly for rectal tumors and early-onset CRC, in a heterogeneous population.
acsjournals.onlinelibrary.wi…
@OncoAlert #CRCSM
6
6
734
New #OpenAccess Clinical Practice Guideline đź“ť Executive summary of American Radium Society Appropriate Use Criteria for the treatment of locoregionally recurrent rectal cancer
acsjournals.onlinelibrary.wi…
@EricMillerMDPhD @OncoAlert
7
10
818
⚖️ Black women face higher risks of early-onset breast cancer, and a new study found inherited cancer-risk variants in 15.3% of young Black women with breast cancer.
Results support the need for broader access to genetic testing:
acsjournals.onlinelibrary.wi…
@OncoAlert @WileyHealth
9
9
714
🧠As the week wraps up, #CancerScope looks at research published in JAMA linking stereotactic radiation to fewer symptoms and improved quality of life for patients with 5–20 brain metastases.
Section Editor Dr. Helen Shih offers commentary:
acsjournals.onlinelibrary.wi…
@OncoAlert
4
8
682
New findings led by @UR_Med & @WilmotCancer researchers suggest that hyperphosphatemia may serve as a potential biomarker of erdafitinib activity among patients with advanced urothelial cancer and warrant prospective validation.
acsjournals.onlinelibrary.wi…
@OncoAlert #uroonc
6
7
615
Cancer research and cycling have something in common: progress comes one mile at a time. đźš´
This July, ACS Chief Scientific Officer @billdahutmd will take on the Pan Ohio Hope Ride to raise funds that support the fight against cancer.
Donate today ⬇️ secure.acsevents.org/site/ST…
1
3
144
Antibody–drug conjugates are transforming the treatment landscape of gynecologic cancers. This review summarizes current evidence, challenges in sequencing & resistance, & future directions for their clinical integration: acsjournals.onlinelibrary.wi…
@OncoAlert @ArantzazuBarqu1
6
10
704
From our new antibody–drug conjugates supplement 📗 This comprehensive review summarizes the current active targets for ADCs in extensive-state small cell lung cancer: acsjournals.onlinelibrary.wi…
@OncoAlert @NSethakorn @Annechiangmd @SclcSMASHERS
1
9
9
857